ReviewPlant biotechnology journal2026
Plant Peptides on the Rise: From Historical Insight to Future Applications.
Review in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Plant peptides constitute a rapidly expanding class of signalling molecules essential to plant physiology, mediating key processes such as development, stress adaptation, and immune responses. This review traces the history of plant peptide research, from the seminal discovery of systemin to the recent identification of non-canonical peptides (NCPs) translated from small open reading frames (sORFs) in non-coding RNAs. We delineate the distinct biosynthetic pathways of canonical peptides (CPs), which undergo proteolytic processing and post-translational modifications, and NCPs, which are directly translated, often without further processing. The diverse biological functions of these peptides span development, reproduction, abiotic stress tolerance, biotic defence, and antimicrobial activity. Furthermore, we discuss emerging agricultural applications, including genetic engineering of peptides, exogenous peptide application, and trait optimization informed by natural peptide variation. Beyond agriculture, many plant peptides exhibit therapeutic potential due to their antimicrobial and anticancer properties. Despite significant advances, challenges remain in functional validation, field application, and scalable production. Future progress will depend on the integration of multi-omics approaches, artificial intelligence (AI)-driven prediction, and precision genome editing to fully harness the transformative potential of plant peptides for crop improvement and novel biopharmaceuticals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.